Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sequential therapy with lithium in chemotherapy-induced vomiting.

A Candido, P Rossi, R Tartaglione

    Tumori
    |December 31, 1985
    PubMed
    Summary

    Lithium carbonate pretreatment significantly reduced chemotherapy-induced vomiting in 80% of patients. This approach shows promise for managing emesis when standard antiemetics are ineffective, with minimal side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comorbidity and in-hospital mortality in peritoneal dialysis patients: data of the Emilia Romagna region of Italy.

    European review for medical and pharmacological sciences·2023
    Same author

    Differences between risk perception and risk-taking are related to impulsivity levels.

    International journal of clinical and health psychology : IJCHP·2022
    Same author

    Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans.

    Cell death & disease·2022
    Same author

    Rituximab in people living with HIV affected by immune-mediated renal diseases: a case-series.

    International journal of STD & AIDS·2020
    Same author

    Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report.

    Transplantation proceedings·2019
    Same author

    Neural correlates of risk perception as a function of risk level: An approach to the study of risk through a daily life task.

    Neuropsychologia·2018

    Area of Science:

    • Oncology
    • Pharmacology
    • Clinical Therapeutics

    Background:

    • Chemotherapy, particularly antineoplastic drugs, can induce severe and intractable vomiting.
    • Psychotic traits have been observed in some patients experiencing this severe emesis.
    • Existing antiemetic therapies like metoclopramide and domperidone have limitations in efficacy.

    Purpose of the Study:

    • To evaluate the effectiveness of lithium carbonate as a prophylactic antiemetic agent.
    • To compare lithium's efficacy against standard antiemetics (metoclopramide, domperidone) in preventing chemotherapy-induced vomiting.
    • To assess the safety and side-effect profile of lithium pretreatment.

    Main Methods:

    • A study involving 40 patients undergoing antineoplastic therapy.

    Related Experiment Videos

  • Pretreatment group received lithium carbonate (600 mg/mq p.o./day for one week) prior to chemotherapy.
  • Control groups received standard antiemetic therapy (metoclopramide and domperidone).

    • Main Results:

    • Lithium pretreatment resulted in favorable outcomes in 80% of patients.
    • Standard antiemetic therapy in control groups showed efficacy in only 55% of cases.
    • Undesirable side effects associated with lithium pretreatment were found to be insignificant.

    Conclusions:

    • Pretreatment with lithium carbonate is an effective strategy for preventing or reducing chemotherapy-induced vomiting.
    • Lithium offers a valuable alternative for selected patients unresponsive to traditional antiemetics.
    • The favorable efficacy and safety profile suggest lithium's potential role in supportive cancer care.